Healthcare Industry News: ExtraCorporeal Circulation
News Release - May 3, 2010
Sorin Group Announces Distribution Agreement with Cardiomedical GmbH for Cardio Vision(TM) Range of Minimally Invasive Surgical InstrumentsAgreement Adds New Product Line to Sorin Core Heart Valves Business Franchise
MILAN--(HSMN NewsFeed)--Sorin Group, (Reuters Code: SORN.MI)(MIL:SRN), a global company and a leader in the treatment of cardiovascular diseases, announced today that it has entered into a distribution agreement, effective May 1, 2010, with CardioMedical GmbH, making Sorin Group, CardioMedical’s selected partner for the entire Cardio Vision™ MIS Portfolio which is a comprehensive catalogue of minimally invasive cardiac surgery instruments and accessories.
The Cardio Vision™ product line is a range of Minimally Invasive Heart Valve Surgery (MIS) instruments including retractors, clamps, forceps, scissors and needle holders. Cardio Vision™ instruments were developed in cooperation with leading cardiac surgeons and include Cardio Vision™’s third generation of tubular shaft instruments incorporating state-of-the-art MIS technology.
“Cardio Vision™’s portfolio has an important strategic fit with our complete range of heart valves and annuloplasty rings and with our Perceval S†, self expanding surgical sutureless valve. This combined offering will empower the surgeon to remove the diseased valve and replace it as minimally invasively as they deem appropriate. This is another example of our continued commitment to provide cardiac surgeons with the best tools, implants and procedures ", said Davide Bianchi, President Heart Valves Business Unit, Sorin Group.
† Perceval S Heart Valve is not available for sale in the USA.
About CardioMedical GmbH
CardioMedical was founded in 1994 in Hanover and manufactures and distributes modern medical quality products for Heart, Thoracic and Vascular Surgery with a special focus on Minimally Invasive Surgery. In 2004 CardioMedical launched its range of products for MIS cardiac surgery called: Cardio Vision™.
For more information, please visit: www.cardiomedical.de
About the Sorin Group
The Sorin Group (www.sorin.com), is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,600 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (ExtraCorporeal Circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over 1 million patients are treated with the devices of Sorin Group in more than 80 countries.
For more information, please visit: www.sorin.com
Source: Sorin Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.